Post-Concussion Cognitive Issues: Causes, Symptoms, and Treatment Options

What Happens to the Brain After a Concussion?

Concussion does not leave the kind of lesion visible on standard CT imaging. Instead, it triggers a neurometabolic cascade: rapid depolarization of neurons floods the intracellular space with potassium, glutamate surges, calcium ions accumulate inside axons, and mitochondrial function drops sharply for 7 to 10 days. The result is an energy deficit in tissue that looks structurally normal on standard MRI but is functionally impaired. Giza and Hovda's seminal 2014 review in Neurosurgery mapped this cascade in detail and remains the foundational model used by most sports medicine and neurology programs today.

Diffuse axonal injury compounds the problem. Rotational and linear acceleration forces stretch white-matter axons throughout the brain, disrupting signal transmission between the prefrontal cortex, hippocampus, and thalamus. Those are exactly the circuits responsible for working memory, attention regulation, and cognitive speed. A 2021 meta-analysis in the Journal of Neurotrauma pooled data from 43 studies (N = 6,482) and found that processing speed was the single most consistently impaired domain at one month post-injury, followed by verbal memory and executive function. [1]

The neurometabolic window matters clinically. Exposing a brain still in the energy-deficit phase to heavy cognitive or physical load prolongs recovery. That is why complete cognitive rest in the first 24 to 48 hours, followed by a structured return-to-activity protocol, remains the standard of care per the 2023 CISG Consensus Statement. [2]

Common Cognitive Symptoms and How Long They Last

Cognitive symptoms after concussion fall into four clusters: memory encoding problems, slowed processing speed, attention and concentration deficits, and executive dysfunction. Patients describe these in practical terms: forgetting a conversation that happened an hour ago, needing to re-read a paragraph three times, losing track of a task mid-step, or struggling to filter out background noise in a conversation.

About 80 to 90 percent of adults who sustain a sport-related concussion recover to baseline neuropsychological test scores within 10 to 14 days. [3] The remaining 10 to 15 percent enter the territory of post-concussion syndrome (PCS), operationally defined in ICD-11 as three or more concussion-related symptoms persisting beyond four weeks, with cognitive complaints among the most common. A 2020 prospective cohort study published in JAMA Neurology (N = 3,063 emergency-department patients) found that 30 percent of adults still reported significant cognitive difficulties at three months, and 15 percent at six months. [4]

Age and sex matter. Patients over 40 show slower neurometabolic recovery, likely because of reduced cerebrovascular reserve. Women have been shown in multiple cohort studies to report longer symptom duration than men after equivalent injuries, though researchers debate whether this reflects biologic differences in white-matter density, hormonal influences on glutamate sensitivity, or simply more accurate symptom reporting. Female sex was an independent predictor of prolonged recovery (OR 1.67 to 95% CI 1.31 to 2.13) in the 2020 JAMA Neurology cohort. [4]

How Post-Concussion Cognitive Deficits Overlap With ADHD

Post-concussion attention deficits and adult ADHD share enough surface features that clinicians sometimes misattribute one to the other. Both conditions produce distractibility, working-memory failures, and difficulty sustaining effort on cognitively demanding tasks. The distinction is timeline and context. ADHD symptoms are present before age 12 by DSM-5 definition, while post-concussion attention deficits emerge after a documented head injury in a patient who previously functioned at a higher level.

The overlap is more than diagnostic inconvenience. Pre-existing ADHD is a recognized risk factor for prolonged post-concussion recovery. A 2019 study in Clinical Journal of Sport Medicine found that adolescent athletes with a prior ADHD diagnosis took 1.7 times longer to receive medical clearance after concussion than neurotypical peers. [5] The mechanism is likely reduced attentional reserve: a brain already taxing its frontal dopaminergic circuits has less redundancy to compensate for the post-injury energy deficit.

For adults newly reporting attention problems after a concussion, a structured differential evaluation is necessary before labeling the condition as ADHD. This includes a verified pre-injury history, standardized neurocognitive testing (the ImPACT battery or CNS Vital Signs platform), and, where available, pre-injury baseline scores. The American Academy of Neurology's 2013 practice guideline on concussion recommends formal neuropsychological evaluation for any patient whose cognitive symptoms persist beyond one month. [6]

When post-concussion attention deficits are severe and disabling, low-dose methylphenidate has evidence behind it. A randomized controlled trial (N = 40) published in Brain Injury showed that methylphenidate 0.3 mg/kg twice daily improved processing speed and sustained attention scores at four weeks compared to placebo in adults with mild TBI. [7] Prescribing decisions should account for concomitant sleep disruption, anxiety, and cardiovascular status.

Narcolepsy, Excessive Daytime Sleepiness, and the Post-Concussion Picture

Excessive daytime sleepiness (EDS) after concussion is underdiagnosed. It can look like cognitive slowing, emotional blunting, or simple fatigue, which leads clinicians to address mood and sleep hygiene while missing a treatable hypersomnia. Post-traumatic hypersomnia has been identified in up to 28 percent of mild TBI patients at three months, based on Epworth Sleepiness Scale scores above 10. [8]

The mechanism connects to hypocretin (orexin) signaling. Traumatic brain injury, including mild TBI, can damage orexinergic neurons in the lateral hypothalamus. A 2014 study in Annals of Neurology (N = 152 TBI patients) found that 19 percent had cerebrospinal fluid hypocretin-1 levels below 110 pg/mL, the diagnostic threshold for narcolepsy type 1, at the six-month mark. [9] This finding places post-traumatic narcolepsy on a spectrum with idiopathic narcolepsy and has direct treatment implications: modafinil 100 to 200 mg/day or armodafinil 150 mg/day may address both EDS and cognitive sluggishness in this subset of patients.

Clinicians evaluating post-concussion patients for cognitive deficits should screen routinely with the Epworth Sleepiness Scale and, where scores exceed 10, consider polysomnography with multiple sleep latency testing to rule out a post-traumatic narcolepsy phenotype.

Diagnosing Post-Concussion Cognitive Issues

Diagnosis relies on a combination of symptom history, standardized questionnaires, and objective neurocognitive testing. No single biomarker has been validated for routine clinical use in PCS, though serum GFAP (glial fibrillary acidic protein) and UCH-L1 are FDA-cleared for acute concussion triage within 12 hours of injury. [10]

For persistent symptoms, the standard evaluation battery includes:

Symptom inventories. The Post-Concussion Symptom Scale (PCSS) and the Rivermead Post-Concussion Symptoms Questionnaire are the most widely used. A PCSS score above 32 in adults at one month correlates with incomplete neurocognitive recovery.

Objective testing. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) platform measures verbal memory, visual memory, processing speed, and reaction time. Scores more than 1.5 standard deviations below age-matched normative data in any domain are clinically significant. The Montreal Cognitive Assessment (MoCA) provides a broader 30-point screen; a score below 26 warrants referral.

Vestibular and oculomotor screening. The Vestibular/Ocular Motor Screening (VOMS) tool identifies vestibular dysfunction that amplifies cognitive symptoms. About 70 percent of PCS patients show at least one VOMS abnormality, and treating vestibular deficits often produces parallel improvement in reported cognitive function.

Mood assessment. Anxiety and depression independently worsen cognitive performance and are present in 40 to 60 percent of PCS patients. The PHQ-9 and GAD-7 should be administered at every follow-up visit because untreated mood disorders predict non-recovery at 12 months. [11]

Non-Pharmacologic Treatment: Graded Aerobic Exercise

The most evidence-supported intervention for persistent post-concussion symptoms is a structured graded aerobic exercise program. This is a significant departure from the old advice of prolonged rest. The Buffalo Concussion Treadmill Test (BCTT) protocol, developed at the University at Buffalo, identifies the heart rate at which symptoms worsen (the symptom-threshold heart rate) and prescribes daily aerobic exercise at 80 percent of that threshold. Patients typically start at 15 to 20 minutes of walking or stationary cycling per day and increase by 5-minute increments every 48 hours as tolerated.

A randomized trial by Leddy et al. published in JAMA Pediatrics (N = 103 adolescents with acute concussion) showed that aerobic exercise started within 10 days of injury reduced the risk of developing PCS at one month by 48 percent compared to a stretching control group. [12] The mechanism is thought to involve normalization of cerebrovascular autoregulation and partial restoration of autonomic nervous system function. Clinicians should prescribe specific heart-rate targets rather than vague activity guidance.

Cognitive rehabilitation therapy (CRT) delivered by a neuropsychologist targets the specific deficits identified on testing. Compensatory strategy training for memory (using external aids, structured repetition, spaced retrieval) is effective when direct remediation of the underlying deficit remains incomplete. A 2022 Cochrane review of cognitive rehabilitation after mild-to-moderate TBI found moderate-quality evidence for attention training improving sustained attention outcomes at three months. [13]

Sleep optimization deserves specific attention. Melatonin 0.5 to 3 mg at bedtime has shown benefit in two small RCTs for post-concussion sleep disruption, and improved sleep architecture correlates with faster cognitive recovery in prospective cohort data. [14] Stimulus-control behavioral interventions should run concurrently because hypnotic medications can worsen daytime cognitive performance.

Pharmacologic Options for Persistent Cognitive Deficits

No drug is FDA-approved specifically for post-concussion cognitive deficits. Prescribing draws on evidence from mild TBI trials, cognitive neurorehabilitation research, and extrapolation from related conditions.

Amantadine. Originally an antiviral and Parkinson's adjunct, amantadine acts as an NMDA receptor antagonist and dopamine agonist. A landmark RCT by Giacino et al. in the New England Journal of Medicine (N = 184 patients with disorders of consciousness after TBI) showed accelerated functional recovery with amantadine 100 to 200 mg twice daily at four weeks. [15] For ambulatory PCS patients with prominent cognitive slowing and apathy, doses of 100 to 200 mg twice daily (total 200 to 400 mg/day) are used off-label, with clinical monitoring for agitation and cardiac QT effects.

Methylphenidate. As noted, 0.3 mg/kg twice daily improves processing speed and sustained attention in mild TBI. [7] Physicians should reassess the need every three months and avoid prescribing without a confirmed cognitive deficit on objective testing.

Modafinil and armodafinil. These are appropriate first choices when post-traumatic hypersomnia or a narcolepsy phenotype is confirmed. Modafinil 100 to 200 mg in the morning does not substantially improve memory encoding or processing speed in patients without EDS, so it is not a general cognitive enhancer in this population.

SSRIs. Sertraline and escitalopram are commonly used when mood symptoms co-occur with cognitive complaints. They do not directly improve neurocognitive test scores but treating depression reduces the functional impact of residual cognitive deficits and may improve motivation for rehabilitation.

Omega-3 fatty acids. DHA supplementation at 2 g/day for 12 weeks showed a trend toward improved processing speed in a 2018 RCT (N = 81 mild TBI patients, P = 0.07), stopping short of statistical significance. [16] Given the safety profile and theoretical mechanism (membrane phospholipid repair), many clinicians include it as an adjunct.

The prescribing clinician should stage treatment: address sleep first, then mood, then cognitive-specific pharmacology. Treating cognitive symptoms in the presence of untreated insomnia or significant depression produces poor outcomes.

Cognitive Decline Risk After Repeated Concussion

Single concussions in otherwise healthy adults do not produce measurable long-term cognitive decline at the population level. Repeated concussions change that calculus. The CDC's Traumatic Brain Injury Data report estimates that 2.87 million TBI-related emergency department visits, hospitalizations, and deaths occurred in the United States in a single recent year, with a substantial proportion involving individuals with prior head injury. [17]

Chronic traumatic encephalopathy (CTE), documented neuropathologically in former contact-sport athletes and military veterans, is characterized by perivascular tau deposition in the neocortex. The Boston University CTE Center has reported CTE pathology in 110 of 111 brains donated by former NFL players, though survivor and donation bias in that sample is significant and must be acknowledged. [18] Clinically, CTE presents with memory problems, behavioral dyscontrol, and later parkinsonism, generally emerging decades after the exposure period.

A 2022 prospective study in The Lancet Neurology (N = 1,875 former professional rugby players, mean follow-up 8.4 years) found that players with three or more career concussions had a 2.5-fold increased risk of mild cognitive impairment compared to matched non-contact-sport controls. [19] This risk gradient underscores the importance of accurate concussion counting, honest reporting culture in sport, and strong return-to-play gatekeeping.

For individual patients with PCS and concerns about long-term risk, the most actionable advice is to reduce modifiable vascular risk factors. Hypertension, insulin resistance, and poor sleep each independently accelerate cognitive aging and amplify the effects of prior TBI. The American Heart Association's 2021 guideline on secondary stroke prevention lists blood pressure control below 130/80 mmHg as a Class I recommendation for any patient with a history of head trauma and vascular risk factors. [20]

Special Populations: Children and Adolescents

Children's brains are not simply small adult brains. The still-myelinating adolescent brain is more vulnerable to the neurometabolic cascade and takes longer to recover at the same injury severity. The 2023 CISG statement notes that return-to-learn protocols should precede and govern return-to-play protocols in school-age patients. [2]

ADHD in children complicates concussion management in the same way it does in adults. A 2017 systematic review in Pediatrics (8 studies, N = 1,492) found that children with pre-existing ADHD reported more post-concussion symptoms and took longer to return to baseline. [21] School accommodations during recovery, including reduced homework load, extended test time, and reduced screen time, should be formally communicated to teachers through a 504 plan or individualized education program when symptoms exceed two weeks.

Stimulant medications prescribed for ADHD before the concussion should generally be continued during recovery. Abrupt discontinuation during the acute window adds attentional stress to an already compromised system and has not been shown to improve recovery. Dose review at the two-week mark is reasonable if insomnia worsens.

When to Refer and What to Expect

Referral to a specialist in concussion or neuropsychology is appropriate when: symptoms exceed four weeks without improvement, the initial neurocognitive testing shows deficits of 1.5 or more standard deviations below norm, mood disorders are not responding to primary-care management, or post-traumatic hypersomnia is suspected.

Most PCS patients who engage actively with a multidisciplinary program (exercise physiology, neuropsychology, vestibular physical therapy, and sleep medicine as needed) recover to functional independence within six months. A minority, perhaps 5 to 8 percent of all concussion patients, have symptoms that persist beyond one year, and those patients benefit from neurologist or physiatrist co-management with ongoing cognitive rehabilitation and pharmacologic adjustment.

The NIH National Institute of Neurological Disorders and Stroke maintains updated patient and clinician resources on TBI and post-concussion management. [22]